Adventist health-care institution’s oncology services are included in Newsweek list for 2021.
Published on: 10-15-2021
Sydney Adventist Hospital in Wahroonga, New South Wales, Australia, has been listed in Newsweek’s World’s Best Specialized Hospitals 2021 report in the area of oncology — the core of which is the San Integrated Cancer Centre.
The Newsweek ranking features the top 250 hospitals in the world for cardiology and oncology, the top 150 for cardiac surgery and pediatrics, and the top 125 in endocrinology, gastroenterology, orthopedics, neurology, neurosurgery, and pulmonology.
The research included institutions in 25 countries and was conducted by market research company Statista in partnership with Newsweek. Data was gathered from three sources: recommendations by doctors via an online survey from the 25 countries; publicly available patient satisfaction survey results; and publicly available medical Key Performance Indicators (KPIs) on hospitals.
Associate professor Gavin Marx, clinical director at the San Integrated Cancer Centre, said the hospital is delighted with the news.
“Over many years, we have developed a high-volume cancer service at the San that incorporates the use of advanced technology with an extremely empathetic approach that treats each patient with unique, individualized care,” he said.
“We offer a rapid access model including the best available diagnostic assessment and senior specialist consultation. It is clear that our highly skilled team, along with constant innovation, has led to excellent patient outcomes and our impressive reputation both in Australia and internationally.”
Key elements of the integrated and multidisciplinary center include state-of-the-art imaging, a full range of high-quality surgical and reconstructive services, comprehensive medical oncology services, expert onsite cancer genetics, and extensive cancer support services.
The co-located Icon Cancer Centre provides the latest in radiation therapy technology and techniques for all cancer types.
The center’s Clinical Trials Unit participates in international trials in breast, colorectal, prostate, melanoma, and other cancers to provide patients with novel medical therapies.
The hospital is also known for its highly engaged patient navigators, who support patients at every point during their time with the San.
CEO Brett Goods said he is extremely proud of the excellent work of the San’s cancer teams and their recognition in an international context.
“The Newsweek ranking builds on the San being noted as an oncology leader in local rankings,” Goods said. “In 2020, for the third consecutive year, the San Integrated Cancer Centre achieved some of the highest ratings in the Bureau of Health Information patient survey, conducted in partnership with the Cancer Institute of NSW [New South Wales].”